The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Åke Borg

Åke Borg

Principal investigator

Åke Borg

Gene-expression profiles in hereditary breast cancer

Author

  • I Hedenfalk
  • D Duggan
  • Y Chen
  • M Radmacher
  • M Bittner
  • R Simon
  • P Meltzer
  • B Gusterson
  • M Esteller
  • O P Kallioniemi
  • B Wilfond
  • Åke Borg
  • J Trent
  • M Raffeld
  • Z Yakhini
  • A Ben-Dor
  • E Dougherty
  • J Kononen
  • L Bubendorf
  • W Fehrle
  • S Pittaluga
  • S Gruvberger
  • N Loman
  • O Johannsson
  • Håkan Olsson
  • G Sauter
Show all

Summary, in English

BACKGROUND: Many cases of hereditary breast cancer are due to mutations in either the BRCA1 or the BRCA2 gene. The histopathological changes in these cancers are often characteristic of the mutant gene. We hypothesized that the genes expressed by these two types of tumors are also distinctive, perhaps allowing us to identify cases of hereditary breast cancer on the basis of gene-expression profiles.

METHODS: RNA from samples of primary tumor from seven carriers of the BRCA1 mutation, seven carriers of the BRCA2 mutation, and seven patients with sporadic cases of breast cancer was compared with a microarray of 6512 complementary DNA clones of 5361 genes. Statistical analyses were used to identify a set of genes that could distinguish the BRCA1 genotype from the BRCA2 genotype.

RESULTS: Permutation analysis of multivariate classification functions established that the gene-expression profiles of tumors with BRCA1 mutations, tumors with BRCA2 mutations, and sporadic tumors differed significantly from each other. An analysis of variance between the levels of gene expression and the genotype of the samples identified 176 genes that were differentially expressed in tumors with BRCA1 mutations and tumors with BRCA2 mutations. Given the known properties of some of the genes in this panel, our findings indicate that there are functional differences between breast tumors with BRCA1 mutations and those with BRCA2 mutations.

CONCLUSIONS: Significantly different groups of genes are expressed by breast cancers with BRCA1 mutations and breast cancers with BRCA2 mutations. Our results suggest that a heritable mutation influences the gene-expression profile of the cancer.

Department/s

  • Breast and Ovarian Cancer Genomics
  • Breastcancer-genetics
  • Familial Breast Cancer
  • Tumor microenvironment

Publishing year

2001-02-22

Language

English

Pages

48-539

Publication/Series

New England Journal of Medicine

Volume

344

Issue

8

Document type

Journal article

Publisher

Massachusetts Medical Society

Topic

  • Cancer and Oncology

Keywords

  • Algorithms
  • BRCA2 Protein
  • Breast Neoplasms
  • DNA Methylation
  • DNA, Complementary
  • DNA, Neoplasm
  • Gene Expression
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Genes, BRCA1
  • Genotype
  • Germ-Line Mutation
  • Heterozygote
  • Humans
  • Neoplasm Proteins
  • Oligonucleotide Array Sequence Analysis
  • RNA, Messenger
  • RNA, Neoplasm
  • Transcription Factors

Status

Published

Research group

  • Breast and Ovarian Cancer Genomics
  • Familial Breast Cancer

ISBN/ISSN/Other

  • ISSN: 0028-4793